Annual ROE
-64.17%
+61.21%+48.82%
31 December 2023
Summary:
CymaBay Therapeutics annual return on equity is currently -64.17%, with the most recent change of +61.21% (+48.82%) on 31 December 2023. During the last 3 years, it has fallen by -33.18% (-107.07%).CBAY ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-60.75%
+10.18%+14.35%
31 December 2023
Summary:
CymaBay Therapeutics quarterly return on equity is currently -60.75%, with the most recent change of +10.18% (+14.35%) on 31 December 2023. Over the past year, it has increased by +10.18% (+14.35%).CBAY Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.8% | +14.3% |
| 3 y3 years | -107.1% | +4.7% |
| 5 y5 years | -12.9% | -39.3% |
CBAY ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -1970.8% | +96.9% |
CymaBay Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -64.17%(-48.8%) | -60.75%(-14.4%) |
| Sept 2023 | - | -70.93%(-31.2%) |
| June 2023 | - | -103.13%(-24.8%) |
| Mar 2023 | - | -137.07%(+8.4%) |
| Dec 2022 | -125.38%(+92.0%) | -126.46%(+12.2%) |
| Sept 2022 | - | -112.67%(+11.9%) |
| June 2022 | - | -100.68%(+12.9%) |
| Mar 2022 | - | -89.14%(+18.3%) |
| Dec 2021 | -65.30%(+110.7%) | -75.32%(+18.1%) |
| Sept 2021 | - | -63.76%(+31.3%) |
| June 2021 | - | -48.55%(+34.4%) |
| Mar 2021 | - | -36.12%(+17.1%) |
| Dec 2020 | -30.99%(-46.2%) | -30.85%(-14.5%) |
| Sept 2020 | - | -36.07%(-11.5%) |
| June 2020 | - | -40.75%(-6.3%) |
| Mar 2020 | - | -43.47%(-10.1%) |
| Dec 2019 | -57.63%(+1.4%) | -48.36%(+10.9%) |
| Sept 2019 | - | -43.60%(+7.7%) |
| June 2019 | - | -40.48%(+5.8%) |
| Mar 2019 | - | -38.25%(-9.9%) |
| Dec 2018 | -56.82% | -42.43%(+12.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | -37.71%(-7.7%) |
| June 2018 | - | -40.87%(-17.7%) |
| Mar 2018 | - | -49.63%(-32.7%) |
| Dec 2017 | -62.01%(-62.7%) | -73.78%(-36.3%) |
| Sept 2017 | - | -115.77%(-72.8%) |
| June 2017 | - | -425.02%(+63.8%) |
| Mar 2017 | - | -259.55%(+25.1%) |
| Dec 2016 | -166.42%(+124.9%) | -207.49%(+52.6%) |
| Sept 2016 | - | -135.98%(+30.9%) |
| June 2016 | - | -103.90%(+31.0%) |
| Mar 2016 | - | -79.30%(+24.5%) |
| Dec 2015 | -74.01%(-62.4%) | -63.67%(-40.5%) |
| Sept 2015 | - | -106.96%(-9.2%) |
| June 2015 | - | -117.84%(-18.7%) |
| Mar 2015 | - | -144.97%(-32.1%) |
| Dec 2014 | -196.74%(+263.2%) | -213.37%(+49.1%) |
| Sept 2014 | - | -143.13%(-0.6%) |
| June 2014 | - | -144.00%(+23.3%) |
| Mar 2014 | - | -116.82%(+115.7%) |
| Dec 2013 | -54.17%(-1679.3%) | -54.16% |
| Dec 2012 | 3.43% | - |
FAQ
- What is CymaBay Therapeutics annual return on equity?
- What is the all time high annual ROE for CymaBay Therapeutics?
- What is CymaBay Therapeutics annual ROE year-on-year change?
- What is CymaBay Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly ROE year-on-year change?
What is CymaBay Therapeutics annual return on equity?
The current annual ROE of CBAY is -64.17%
What is the all time high annual ROE for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual return on equity is 3.43%
What is CymaBay Therapeutics annual ROE year-on-year change?
Over the past year, CBAY annual return on equity has changed by +61.21% (+48.82%)
What is CymaBay Therapeutics quarterly return on equity?
The current quarterly ROE of CBAY is -60.75%
What is the all time high quarterly ROE for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly return on equity is -30.85%
What is CymaBay Therapeutics quarterly ROE year-on-year change?
Over the past year, CBAY quarterly return on equity has changed by +10.18% (+14.35%)